INNOVADERM CRO IS NOW INDERO.

Dr. Robert Bissonnette and Dr. Kim Papp on Shaping the Future of Clinical Research

Indero

Indero

Team of Experts

Author picture

Amidst the vibrant atmosphere of the EADV in Berlin, Dr. Bissonnette from Innovaderm Research and Dr. Papp from Probity Medical Research seized a rare moment between presentations to engage in a compelling conversation.

These industry leaders share a common journey—the conception and evolution of their clinical research companies, which began as local endeavors in Canada and blossomed into influential international entities. The pair covered some of the main challenges encountered with conducting vitiligo studies, the intricacies of early phase studies, and offering insights into alopecia areata studies. This exclusive interview will bring to light the historical roots of both organizations and explore the ambitious trajectories envisioned for their respective future.

Listen to the full interview below:

SHARE THIS POST

Subscribe to our newsletter.

Do not miss out on valuable insights and research updates. Join our scientific community today!

Fields marked with * are required.

Jeff Smith

Chef de la direction

Jeff Smith, Chef de la direction d’Indero Recherches, apporte prĂšs de 30 ans d’expĂ©rience dans l’industrie pharmaceutique et CRO, s’Ă©tant distinguĂ© par son leadership exceptionnel, sa vision stratĂ©gique et son innovation. L’expertise de Jeff couvre des opĂ©rations mondiales, la gestion de la croissance, ainsi que la promotion d’une culture d’entreprise collaborative. Ses atouts en matiĂšre de crĂ©ation de valeur, de gestion des partenaires et d’opĂ©rations CRO ont toujours contribuĂ© au succĂšs dans ses fonctions prĂ©cĂ©dentes. Sous la direction de Jeff, Indero continue d’étendre ses capacitĂ©s, faisant progresser les connaissances mĂ©dicales et les nouvelles thĂ©rapies en dermatologie et en rhumatologie.